Sermorelin + GHRP-6 Blend – Product Information
Sermorelin and GHRP-6 (Growth Hormone Releasing Peptide-6) are frequently combined in a research setting as a blend for the stimulation of growth hormone (GH) release. This combination can potentially enhance the effectiveness of growth hormone therapy.
When Sermorelin and GHRP-6 are combined as a blend, they may work synergistically to amplify the release of GH. Sermorelin acts as a growth hormone-releasing hormone, stimulating the pituitary gland, while GHRP-6 directly activates the growth hormone secretagogue receptors. Together, they may provide a more potent and sustained increase in GH levels compared to either peptide alone.
- Sermorelin + GHRP-6 Blend consists of two compounds: Sermorelin and GHRP-6.
- Sermorelin + GHRP-6 Blend contains 5mg of Sermorelin and 5mg of GHRP-6, totaling 10mg.
Sermorelin is a growth hormone-releasing hormone (GHRH) analog currently used in a clinical setting to evaluate growth hormone secretion. It is of interest to researchers for its potential ability to improve bone density, diminish scaring, combat the effects of dementia, and reduce seizure activity.
|Molar Mass||3357.93 g·mol−1|
Growth hormone-releasing peptide (GHRP-6) is a synthetic hexapeptide that specifically stimulates the secretion of growth hormone (GH) by pituitary somatotrophs. Growth hormone (GH) release is stimulated by a variety of synthetic secretagogues, of which growth hormone-releasing hexapeptide (GHRP-6) has been most thoroughly studied; it is thought to have actions at both pituitary and hypothalamic sites.
|Molar Mass||873.032 g·mol−1|